Stable ophthalmic composition comprising latanoprost
OwnerJens Flemming, Harm Peters +4inventors
InventorsJens Flemming, Harm Peters, Sunghak Choi, Kangok Lee, Jinsook Ko, Youngwoon Park
Life of this patent
Estimating the term…
Abstract
The present invention refers to an aqueous ophthalmic composition comprising latanoprost in an amount of 0.003 weight-% to 0.007 weight-%, macrogolglycerol hydroxystearate 40 in an amount of 0.3 weight-% to 0.7 weight-%, and propylene glycol in an amount of 0.05 weight-% to 0.09 weight-%, wherein the composition is free of preservatives and stabilizing agents. Furthermore, the present invention refers to the use in the treatment of ocular hypertension and/or glaucoma.
Claims15
An aqueous ophthalmic composition comprising latanoprost in an amount of 0.003 weight-% to 0.007 weight-%, macrogolglycerol hydroxystearate 40 in an amount of 0.3 weight-% to 0.7 weight-%, and propylene glycol in an amount of 0.05 weight-% to 0.09 weight-%, wherein the composition is free of preservatives and stabilizing agents.
Dependencies are inferred from the claim text.